SCTX

Scribe Therapeutics Inc. Common Stock (SCTX)

Stock · NASDAQ · Health Care

$28.49as of 8/28/2026

Active signals

Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Fundamentals

Market cap
$411.18M
P/E (trailing)
P/E (forward)
EPS (trailing)
Dividend yield
Beta
Avg. volume

Scribe Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • SCTX
    Scribe Therapeutics Inc. Common Stock
    $28.44
    ▼ 1.39%
    Market cap $411.18MP/E
  • OCGN
    Ocugen Inc. Common Stock
    $1.32
    ▼ 3.65%
    Market cap $420.50MP/E
    $1$2.73
  • STRO
    Sutro Biopharma Inc. Common Stock
    $20.42
    ▼ 4.18%
    Market cap $400.18MP/E
    $7.15$43.85
  • XFOR
    X4 Pharmaceuticals Inc. Common Stock
    $4.05
    ▼ 4.26%
    Market cap $393.31MP/E 3.24
    $2.8$4.83
  • CABA
    Cabaletta Bio Inc. Common Stock
    $3.11
    ▼ 7.99%
    Market cap $450.03MP/E
    $1.4$4.23
  • PALI
    Palisade Bio Inc. Common Stock
    $2.01
    ▼ 4.74%
    Market cap $362.78MP/E
    $0.53$2.86
  • LXEO
    Lexeo Therapeutics Inc. Common Stock
    $4.87
    ▼ 2.51%
    Market cap $357.27MP/E
    $3.99$10.99

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
6.96M
Disposed
18.42M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.